1. Home
  2. LARK vs GNLX Comparison

LARK vs GNLX Comparison

Compare LARK & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LARK
  • GNLX
  • Stock Information
  • Founded
  • LARK 1885
  • GNLX 2001
  • Country
  • LARK United States
  • GNLX United States
  • Employees
  • LARK N/A
  • GNLX N/A
  • Industry
  • LARK Major Banks
  • GNLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • LARK Finance
  • GNLX Health Care
  • Exchange
  • LARK Nasdaq
  • GNLX Nasdaq
  • Market Cap
  • LARK 142.3M
  • GNLX 128.0M
  • IPO Year
  • LARK N/A
  • GNLX 2023
  • Fundamental
  • Price
  • LARK $27.25
  • GNLX $4.07
  • Analyst Decision
  • LARK
  • GNLX Strong Buy
  • Analyst Count
  • LARK 0
  • GNLX 4
  • Target Price
  • LARK N/A
  • GNLX $17.75
  • AVG Volume (30 Days)
  • LARK 5.8K
  • GNLX 151.7K
  • Earning Date
  • LARK 10-29-2025
  • GNLX 11-13-2025
  • Dividend Yield
  • LARK 3.10%
  • GNLX N/A
  • EPS Growth
  • LARK 42.91
  • GNLX N/A
  • EPS
  • LARK 2.81
  • GNLX N/A
  • Revenue
  • LARK $62,413,000.00
  • GNLX N/A
  • Revenue This Year
  • LARK N/A
  • GNLX N/A
  • Revenue Next Year
  • LARK N/A
  • GNLX N/A
  • P/E Ratio
  • LARK $9.69
  • GNLX N/A
  • Revenue Growth
  • LARK 11.63
  • GNLX N/A
  • 52 Week Low
  • LARK $18.81
  • GNLX $1.95
  • 52 Week High
  • LARK $31.04
  • GNLX $5.89
  • Technical
  • Relative Strength Index (RSI)
  • LARK 57.91
  • GNLX 63.26
  • Support Level
  • LARK $26.55
  • GNLX $3.76
  • Resistance Level
  • LARK $27.24
  • GNLX $4.21
  • Average True Range (ATR)
  • LARK 0.36
  • GNLX 0.26
  • MACD
  • LARK 0.02
  • GNLX 0.05
  • Stochastic Oscillator
  • LARK 81.33
  • GNLX 84.62

About LARK Landmark Bancorp Inc.

Landmark Bancorp Inc is the bank holding company for Landmark National Bank, which is dedicated to providing quality financial and banking services. The Bank has continued to focus on increasing its originations of commercial, commercial real estate (CRE), and agricultural loans, which management believes will be more profitable and provide more growth for the Bank than traditional one-to-four-family residential real estate lending. In addition, it also invests in certain investment and mortgage-related securities using deposits and other borrowings as funding sources. Its primary deposit gathering and lending markets are geographically diversified with locations in central, eastern, southeast, and southwest Kansas.

About GNLX Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.

Share on Social Networks: